Rebates for Medicaid Physician-Administered and Pharmacy Drug Claims

States are generally required to collect manufacturer rebates on physician-administered and pharmacy drugs in order to receive Federal matching funds for those drugs. Previous OIG work identified significant concerns with States' efforts in obtaining rebates for physician-administered drug claims. We will follow up with select States to determine whether States have implemented controls to ensure ongoing compliance with Federal Medicaid drug rebate requirements.

Announced or Revised	Agency	Title	Component	Report Number(s)	Expected Issue Date (FY)
November 2025	CMS	Rebates for Medicaid Physician-Administered and Pharmacy Drug Claims	Office of Audit Services	OAS-26-07-009; SRS-A-26-002	2027